Abbott Laboratories Stock - Citi sees upside after fresh valuation call
17.06.2026 - 19:19:17 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 17:15 UTC. Details in the imprint.
Abbott Laboratories (US0028241000) sits back in the analyst spotlight midweek. On 06/17/2026 Citi outlined upside potential for the stock to a range of $99 to $104, citing sum-of-the-parts valuation work on the healthcare group’s main segments according to a Citi-focused report.
All news and analysis on Abbott Laboratories stock
Track fresh analyst calls, quarterly updates and price data on Abbott Laboratories stock in one place.
What Citi now highlights
The Citi work, summarized on 06/17/2026, argues that Abbott’s individual divisions justify a higher combined equity value than the current market capitalization, pointing to a $99 to $104 per-share value band versus a spot price around the low $90s.
According to the analysis, Abbott’s cardiovascular and diabetes devices, diagnostics, and nutrition businesses underpin the upside case, helped by a forward-looking pipeline that could ease recent headwinds and support earnings growth over time.
Midweek operations and strategy view
Operationally, Abbott remains diversified across medical devices, diagnostics, established pharmaceuticals and nutrition, with management emphasizing balanced growth and disciplined capital allocation in recent quarterly communications on its investor pages.
In the first quarter of 2026 Abbott reported earnings per share of $1.15, slightly above the $1.14 consensus, underscoring a steady margin profile as the company works through the post-pandemic normalization in testing volumes and broader healthcare spending trends.
How Abbott makes its money
Abbott generates revenue primarily from medical devices for cardiovascular and diabetes care, diagnostics systems for labs and point-of-care testing, a portfolio of branded generic medicines in emerging markets, and nutrition products for infants, children and adults.
Where the stock trades today
Abbott Laboratories shares (US0028241000) trade on the New York Stock Exchange at $89.86 as of 06/17/2026, 14:02 ET.
Key facts on Abbott Laboratories stock
- Company: Abbott Laboratories Inc.
- ISIN: US0028241000
- WKN: 850103
- Ticker: ABT
- Venue: NYSE
- Price (as of 06/17/2026, 14:02 ET): 89.86 USD
- Market cap: 154.45 billion USD (as of 06/15/2026)
- Sector / Industry: Health Care / Health Care Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: 07/17/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
